Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Guardat en:

Dades bibliogràfiques
Publicat a:	Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Autor principal:	Niazi, Sarfaraz K
Publicat:	MDPI AG
Matèries:	Food & Drug Administration > FDA United States > US Germany Monoclonal antibodies Product quality Collaboration Real time Batch processes Process controls Biological products Pharmaceutical industry Capital expenditures Batch processing Manufacturing Cost control 19th century Product testing
Accés en línia:	Citation/Abstract Full Text + Graphics Full Text - PDF
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Sigues el primer a deixar un comentari!